| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-95 |
Sentence |
denotes |
Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. |
| T1 |
0-95 |
Sentence |
denotes |
Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. |
| TextSentencer_T2 |
96-242 |
Sentence |
denotes |
Prostate cancer is the most common solid tumor in men, and it shares with all cancers the hallmark of elevated, nonhomeostatic cell proliferation. |
| T2 |
96-242 |
Sentence |
denotes |
Prostate cancer is the most common solid tumor in men, and it shares with all cancers the hallmark of elevated, nonhomeostatic cell proliferation. |
| TextSentencer_T3 |
243-363 |
Sentence |
denotes |
Here we have tested the hypothesis that the SONIC HEDGEHOG (SHH)-GLI signaling pathway is implicated in prostate cancer. |
| T3 |
243-363 |
Sentence |
denotes |
Here we have tested the hypothesis that the SONIC HEDGEHOG (SHH)-GLI signaling pathway is implicated in prostate cancer. |
| TextSentencer_T4 |
364-518 |
Sentence |
denotes |
We report expression of SHH-GLI pathway components in adult human prostate cancer, often with enhanced levels in tumors versus normal prostatic epithelia. |
| T4 |
364-518 |
Sentence |
denotes |
We report expression of SHH-GLI pathway components in adult human prostate cancer, often with enhanced levels in tumors versus normal prostatic epithelia. |
| TextSentencer_T5 |
519-653 |
Sentence |
denotes |
Blocking the pathway with cyclopamine or anti-SHH antibodies inhibits the proliferation of GLI1+/PSA+ primary prostate tumor cultures. |
| T5 |
519-653 |
Sentence |
denotes |
Blocking the pathway with cyclopamine or anti-SHH antibodies inhibits the proliferation of GLI1+/PSA+ primary prostate tumor cultures. |
| TextSentencer_T6 |
654-777 |
Sentence |
denotes |
Inversely, SHH can potentiate tumor cell proliferation, suggesting that autocrine signaling may often sustain tumor growth. |
| T6 |
654-777 |
Sentence |
denotes |
Inversely, SHH can potentiate tumor cell proliferation, suggesting that autocrine signaling may often sustain tumor growth. |
| TextSentencer_T7 |
778-1068 |
Sentence |
denotes |
In addition, pathway blockade in three metastatic prostate cancer cell lines with cyclopamine or through GLI1 RNA interference leads to inhibition of cell proliferation, suggesting cell-autonomous pathway activation at different levels and showing an essential role for GLI1 in human cells. |
| T7 |
778-1068 |
Sentence |
denotes |
In addition, pathway blockade in three metastatic prostate cancer cell lines with cyclopamine or through GLI1 RNA interference leads to inhibition of cell proliferation, suggesting cell-autonomous pathway activation at different levels and showing an essential role for GLI1 in human cells. |
| TextSentencer_T8 |
1069-1185 |
Sentence |
denotes |
Our data demonstrate the dependence of prostate cancer on SHH-GLI function and suggest a novel therapeutic approach. |
| T8 |
1069-1185 |
Sentence |
denotes |
Our data demonstrate the dependence of prostate cancer on SHH-GLI function and suggest a novel therapeutic approach. |